"World's Most Complete Market Research Reports Repository"

Global Meningococcal Infections Vaccine Market Insights, Forecast to 2025

This report studies the global market size of Meningococcal Infections Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Meningococcal Infections Vaccine in these regions.
This research report categorizes the global Meningococcal Infections Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Meningococcal Infections Vaccine market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Meningococcal Infections Vaccine market based on company, product type, application and key regions.

The various contributors involved in the value chain of Meningococcal Infections Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Meningococcal Infections Vaccine include
Sanofi-Pasteur
Beijing Tiantan Biological Products
Shanghai Institute of Biological Products
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products
Hualan Biological Engineering
Chongqing Zhifei Biological Products
Zhejiang Tianyuan Bio-Pharmaceutical
Walvax Biotechnology
Royal(Wuxi) Bio-Pharmaceutical

Market Size Split by Type
Meningococcal Conjugate Vaccines
Meningococcal Polysaccharide Vaccine
Serogroup B Meningococcal Vaccine
Market Size Split by Application
Children
Preteens/Teens
Adults

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Meningococcal Infections Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Meningococcal Infections Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Meningococcal Infections Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Meningococcal Infections Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Meningococcal Infections Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Meningococcal Infections Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Meningococcal Infections Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Meningococcal Infections Vaccine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Meningococcal Infections Vaccine Market Size Growth Rate by Type
1.4.2 Meningococcal Conjugate Vaccines
1.4.3 Meningococcal Polysaccharide Vaccine
1.4.4 Serogroup B Meningococcal Vaccine
1.5 Market by Application
1.5.1 Global Meningococcal Infections Vaccine Market Size Growth Rate by Application
1.5.2 Children
1.5.3 Preteens/Teens
1.5.4 Adults
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Meningococcal Infections Vaccine Market Size
2.1.1 Global Meningococcal Infections Vaccine Revenue 2016-2025
2.1.2 Global Meningococcal Infections Vaccine Sales 2016-2025
2.2 Meningococcal Infections Vaccine Growth Rate by Regions
2.2.1 Global Meningococcal Infections Vaccine Sales by Regions
2.2.2 Global Meningococcal Infections Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Meningococcal Infections Vaccine Sales by Manufacturers
3.1.1 Meningococcal Infections Vaccine Sales by Manufacturers
3.1.2 Meningococcal Infections Vaccine Sales Market Share by Manufacturers
3.1.3 Global Meningococcal Infections Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Meningococcal Infections Vaccine Revenue by Manufacturers
3.2.1 Meningococcal Infections Vaccine Revenue by Manufacturers (2016-2018)
3.2.2 Meningococcal Infections Vaccine Revenue Share by Manufacturers (2016-2018)
3.3 Meningococcal Infections Vaccine Price by Manufacturers
3.4 Meningococcal Infections Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Meningococcal Infections Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meningococcal Infections Vaccine Product Category
3.4.3 Date of International Manufacturers Enter into Meningococcal Infections Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Meningococcal Infections Vaccine Sales by Type
4.2 Global Meningococcal Infections Vaccine Revenue by Type
4.3 Meningococcal Infections Vaccine Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Meningococcal Infections Vaccine Breakdown Data by Application

6 North America
6.1 North America Meningococcal Infections Vaccine by Countries
6.1.1 North America Meningococcal Infections Vaccine Sales by Countries
6.1.2 North America Meningococcal Infections Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Meningococcal Infections Vaccine by Type
6.3 North America Meningococcal Infections Vaccine by Application
6.4 North America Meningococcal Infections Vaccine by Company

7 Europe
7.1 Europe Meningococcal Infections Vaccine by Countries
7.1.1 Europe Meningococcal Infections Vaccine Sales by Countries
7.1.2 Europe Meningococcal Infections Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Meningococcal Infections Vaccine by Type
7.3 Europe Meningococcal Infections Vaccine by Application
7.4 Europe Meningococcal Infections Vaccine by Company

8 Asia Pacific
8.1 Asia Pacific Meningococcal Infections Vaccine by Countries
8.1.1 Asia Pacific Meningococcal Infections Vaccine Sales by Countries
8.1.2 Asia Pacific Meningococcal Infections Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Meningococcal Infections Vaccine by Type
8.3 Asia Pacific Meningococcal Infections Vaccine by Application
8.4 Asia Pacific Meningococcal Infections Vaccine by Company

9 Central & South America
9.1 Central & South America Meningococcal Infections Vaccine by Countries
9.1.1 Central & South America Meningococcal Infections Vaccine Sales by Countries
9.1.2 Central & South America Meningococcal Infections Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Meningococcal Infections Vaccine by Type
9.3 Central & South America Meningococcal Infections Vaccine by Application
9.4 Central & South America Meningococcal Infections Vaccine by Company

10 Middle East and Africa
10.1 Middle East and Africa Meningococcal Infections Vaccine by Countries
10.1.1 Middle East and Africa Meningococcal Infections Vaccine Sales by Countries
10.1.2 Middle East and Africa Meningococcal Infections Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Meningococcal Infections Vaccine by Type
10.3 Middle East and Africa Meningococcal Infections Vaccine by Application
10.4 Middle East and Africa Meningococcal Infections Vaccine by Company

11 Company Profiles
11.1 Sanofi-Pasteur
11.1.1 Sanofi-Pasteur Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Meningococcal Infections Vaccine
11.1.4 Meningococcal Infections Vaccine Product Description
11.1.5 Recent Development
11.2 Beijing Tiantan Biological Products
11.2.1 Beijing Tiantan Biological Products Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Meningococcal Infections Vaccine
11.2.4 Meningococcal Infections Vaccine Product Description
11.2.5 Recent Development
11.3 Shanghai Institute of Biological Products
11.3.1 Shanghai Institute of Biological Products Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Meningococcal Infections Vaccine
11.3.4 Meningococcal Infections Vaccine Product Description
11.3.5 Recent Development
11.4 Wuhan Institute of Biological Products
11.4.1 Wuhan Institute of Biological Products Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Meningococcal Infections Vaccine
11.4.4 Meningococcal Infections Vaccine Product Description
11.4.5 Recent Development
11.5 Lanzhou Institute of Biological Products
11.5.1 Lanzhou Institute of Biological Products Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Meningococcal Infections Vaccine
11.5.4 Meningococcal Infections Vaccine Product Description
11.5.5 Recent Development
11.6 Hualan Biological Engineering
11.6.1 Hualan Biological Engineering Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Meningococcal Infections Vaccine
11.6.4 Meningococcal Infections Vaccine Product Description
11.6.5 Recent Development
11.7 Chongqing Zhifei Biological Products
11.7.1 Chongqing Zhifei Biological Products Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Meningococcal Infections Vaccine
11.7.4 Meningococcal Infections Vaccine Product Description
11.7.5 Recent Development
11.8 Zhejiang Tianyuan Bio-Pharmaceutical
11.8.1 Zhejiang Tianyuan Bio-Pharmaceutical Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Meningococcal Infections Vaccine
11.8.4 Meningococcal Infections Vaccine Product Description
11.8.5 Recent Development
11.9 Walvax Biotechnology
11.9.1 Walvax Biotechnology Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Meningococcal Infections Vaccine
11.9.4 Meningococcal Infections Vaccine Product Description
11.9.5 Recent Development
11.10 Royal(Wuxi) Bio-Pharmaceutical
11.10.1 Royal(Wuxi) Bio-Pharmaceutical Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Meningococcal Infections Vaccine
11.10.4 Meningococcal Infections Vaccine Product Description
11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Meningococcal Infections Vaccine Raw Material
13.1.2 Meningococcal Infections Vaccine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Picture of Meningococcal Infections Vaccine
Figure Global Meningococcal Infections Vaccine Production (K doses) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Meningococcal Infections Vaccine Production Market Share by Types (Product Category) in 2017
Figure Meningococcal Conjugate Vaccines Product Picture
Table Major Manufacturers of Meningococcal Conjugate Vaccines
Figure Meningococcal Polysaccharide Vaccine Product Picture
Table Major Manufacturers of Meningococcal Polysaccharide Vaccine
Figure Serogroup B Meningococcal Vaccine Product Picture
Table Major Manufacturers of Serogroup B Meningococcal Vaccine
Table Global Meningococcal Infections Vaccine Market Size Growth Rate by Application 2018-2025 (K doses)
Figure Children
Figure Preteens/Teens
Figure Adults
Figure Meningococcal Infections Vaccine Report Years Considered
Figure Global Meningococcal Infections Vaccine Market Size 2016-2025 (Million US$)
Figure Global Meningococcal Infections Vaccine Sales 2016-2025 (K doses)
Table Global Meningococcal Infections Vaccine Market Size by Regions 2016-2025 (K doses) & (Million US$)
Table Global Meningococcal Infections Vaccine Sales by Regions 2016-2025 (K doses)
Table Global Meningococcal Infections Vaccine Sales Market Share by Regions 2016-2025
Figure Global Meningococcal Infections Vaccine Sales Market Share by Regions 2016-2025
Figure 2017 Global Meningococcal Infections Vaccine Sales Market Share by Regions
Table Global Meningococcal Infections Vaccine Revenue by Regions 2016-2025 (Million US$)
Table Global Meningococcal Infections Vaccine Revenue Market Share by Regions 2016-2025
Figure Global Meningococcal Infections Vaccine Revenue Market Share by Regions 2016-2025
Figure 2017 Global Meningococcal Infections Vaccine Revenue Market Share by Regions
Table Global Meningococcal Infections Vaccine Sales by Manufacturers (2016-2018) (K doses)
Table Global Meningococcal Infections Vaccine Sales Share by Manufacturers (2016-2018)
Figure Global Meningococcal Infections Vaccine Sales Share by Manufacturers in 2017
Table Meningococcal Infections Vaccine Revenue by Manufacturers (2016-2018) (Million US$)
Table Meningococcal Infections Vaccine Revenue Share by Manufacturers (2016-2018)
Figure Meningococcal Infections Vaccine Value Share by Manufacturers in 2017
Table Global Meningococcal Infections Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Meningococcal Infections Vaccine Price (2016-2018) (USD/dose)
Table Meningococcal Infections Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Meningococcal Infections Vaccine Product Category
Table Date of International Manufacturers Enter into Meningococcal Infections Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Meningococcal Infections Vaccine Sales by Type (2016-2025) (K doses)
Table Global Meningococcal Infections Vaccine Sales Share by Type (2016-2025)
Figure Global Meningococcal Infections Vaccine Sales Market Share by Type (2016-2025)
Figure Global Meningococcal Infections Vaccine Sales Market Share by Type in 2017
Table Global Meningococcal Infections Vaccine Revenue by Type (2016-2025) (Million US$)
Table Global Meningococcal Infections Vaccine Revenue Share by Type (2016-2025)
Figure Global Meningococcal Infections Vaccine Revenue Market Share by Type (2016-2025)
Figure Global Meningococcal Infections Vaccine Revenue Market Share by Type in 2017
Table Meningococcal Infections Vaccine Price by Type 2013-2018 (USD/dose)
Table Global Meningococcal Infections Vaccine Sales by Application (2016-2025) (K doses)
Table Global Meningococcal Infections Vaccine Sales Share by Application (2016-2025)
Figure Global Sales Meningococcal Infections Vaccine Market Share by Application (2016-2025)
Figure Global Sales Meningococcal Infections Vaccine Market Share by Application (2016-2025)
Figure North America Meningococcal Infections Vaccine Sales Growth Rate 2016-2025 (K doses)
Figure North America Meningococcal Infections Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table North America Meningococcal Infections Vaccine Sales by Countries (2016-2025) (K doses)
Table North America Meningococcal Infections Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 North America Meningococcal Infections Vaccine Sales Market Share by Countries
Table North America Meningococcal Infections Vaccine Revenue by Countries (2016-2025) (Million US$)
Table North America Meningococcal Infections Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Meningococcal Infections Vaccine Revenue Market Share by Countries
Figure United States Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure United States Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Canada Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Mexico Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table North America Meningococcal Infections Vaccine Sales by Type (2016-2025) (K doses)
Table North America Meningococcal Infections Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 North America Meningococcal Infections Vaccine Market Share by Type
Table North America Meningococcal Infections Vaccine Sales by Application (2016-2025) (K doses)
Table North America Meningococcal Infections Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 North America Meningococcal Infections Vaccine Market Share by Application
Table North America Meningococcal Infections Vaccine Sales by Company (2016-2018) (K doses)
Table North America Meningococcal Infections Vaccine Sales Market Share by Company (2016-2018)
Figure North America Meningococcal Infections Vaccine Sales Market Share by Company in 2017
Figure Europe Meningococcal Infections Vaccine Sales Growth Rate 2016-2025 (K doses)
Figure Europe Meningococcal Infections Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Meningococcal Infections Vaccine Sales by Countries (2016-2025) (K doses)
Table Europe Meningococcal Infections Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Meningococcal Infections Vaccine Sales Market Share by Countries
Table Europe Meningococcal Infections Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Europe Meningococcal Infections Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Meningococcal Infections Vaccine Revenue Market Share by Countries
Figure Germany Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Germany Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (K doses)
Figure France Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure France Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (K doses)
Figure UK Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure UK Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Italy Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Russia Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Meningococcal Infections Vaccine Sales by Type (2016-2025) (K doses)
Table Europe Meningococcal Infections Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Europe Meningococcal Infections Vaccine Market Share by Type
Table Europe Meningococcal Infections Vaccine Sales by Application (2016-2025) (K doses)
Table Europe Meningococcal Infections Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Europe Meningococcal Infections Vaccine Market Share by Application
Table Europe Meningococcal Infections Vaccine Sales by Company (2016-2018) (K doses)
Table Europe Meningococcal Infections Vaccine Sales Market Share by Company (2016-2018)
Figure Europe Meningococcal Infections Vaccine Sales Market Share by Company in 2017
Figure Asia Pacific Meningococcal Infections Vaccine Sales Growth Rate 2016-2025 (K doses)
Figure Asia Pacific Meningococcal Infections Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Meningococcal Infections Vaccine Sales by Countries (2016-2025) (K doses)
Table Asia Pacific Meningococcal Infections Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Meningococcal Infections Vaccine Sales Market Share by Countries
Table Asia Pacific Meningococcal Infections Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Meningococcal Infections Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Meningococcal Infections Vaccine Revenue Market Share by Countries
Figure China Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure China Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Japan Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Korea Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure India Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure India Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Australia Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Indonesia Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Malaysia Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Philippines Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Thailand Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Vietnam Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Singapore Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Meningococcal Infections Vaccine Sales by Type (2016-2025) (K doses)
Table Asia Pacific Meningococcal Infections Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Meningococcal Infections Vaccine Market Share by Type
Table Asia Pacific Meningococcal Infections Vaccine Sales by Application (2016-2025) (K doses)
Table Asia Pacific Meningococcal Infections Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Meningococcal Infections Vaccine Market Share by Application
Table Asia Pacific Meningococcal Infections Vaccine Sales by Company (2016-2018) (K doses)
Table Asia Pacific Meningococcal Infections Vaccine Sales Market Share by Company (2016-2018)
Figure Asia Pacific Meningococcal Infections Vaccine Sales Market Share by Company in 2017
Figure Central & South America Meningococcal Infections Vaccine Sales Growth Rate 2016-2025 (K doses)
Figure Central & South America Meningococcal Infections Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Meningococcal Infections Vaccine Sales by Countries (2016-2025) (K doses)
Table Central & South America Meningococcal Infections Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Meningococcal Infections Vaccine Sales Market Share by Countries
Table Central & South America Meningococcal Infections Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Meningococcal Infections Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Meningococcal Infections Vaccine Revenue Market Share by Countries
Figure Brazil Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Brazil Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Argentina Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Meningococcal Infections Vaccine Sales by Type (2016-2025) (K doses)
Table Central & South America Meningococcal Infections Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Meningococcal Infections Vaccine Market Share by Type
Table Central & South America Meningococcal Infections Vaccine Sales by Application (2016-2025) (K doses)
Table Central & South America Meningococcal Infections Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Meningococcal Infections Vaccine Market Share by Application
Table Central & South America Meningococcal Infections Vaccine Sales by Company (2016-2018) (K doses)
Table Central & South America Meningococcal Infections Vaccine Sales Market Share by Company (2016-2018)
Figure Central & South America Meningococcal Infections Vaccine Sales Market Share by Company in 2017
Figure Middle East and Africa Meningococcal Infections Vaccine Sales Growth Rate 2016-2025 (K doses)
Figure Middle East and Africa Meningococcal Infections Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Meningococcal Infections Vaccine Sales by Countries (2016-2025) (K doses)
Table Middle East and Africa Meningococcal Infections Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Meningococcal Infections Vaccine Sales Market Share by Countries
Table Middle East and Africa Meningococcal Infections Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Meningococcal Infections Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Meningococcal Infections Vaccine Revenue Market Share by Countries
Figure GCC Countries Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure GCC Countries Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Turkey Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure Egypt Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Meningococcal Infections Vaccine Sales Growth Rate (2016-2025) (K doses)
Figure South Africa Meningococcal Infections Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Meningococcal Infections Vaccine Sales by Type (2016-2025) (K doses)
Table Middle East and Africa Meningococcal Infections Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Meningococcal Infections Vaccine Market Share by Type
Table Middle East and Africa Meningococcal Infections Vaccine Sales by Application (2016-2025) (K doses)
Table Middle East and Africa Meningococcal Infections Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Meningococcal Infections Vaccine Market Share by Application
Table Middle East and Africa Meningococcal Infections Vaccine Sales by Company (2016-2018) (K doses)
Table Middle East and Africa Meningococcal Infections Vaccine Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Meningococcal Infections Vaccine Sales Market Share by Company in 2017
Table Sanofi-Pasteur Company Details
Table Sanofi-Pasteur Meningococcal Infections Vaccine Sales (K doses), Revenue (Million US$), Price (USD/dose) and Gross Margin (2016-2018)
Table Sanofi-Pasteur Recent Development
Table Beijing Tiantan Biological Products Company Details
Table Beijing Tiantan Biological Products Meningococcal Infections Vaccine Sales (K doses), Revenue (Million US$), Price (USD/dose) and Gross Margin (2016-2018)
Table Beijing Tiantan Biological Products Recent Development
Table Shanghai Institute of Biological Products Company Details
Table Shanghai Institute of Biological Products Meningococcal Infections Vaccine Sales (K doses), Revenue (Million US$), Price (USD/dose) and Gross Margin (2016-2018)
Table Shanghai Institute of Biological Products Recent Development
Table Wuhan Institute of Biological Products Company Details
Table Wuhan Institute of Biological Products Meningococcal Infections Vaccine Sales (K doses), Revenue (Million US$), Price (USD/dose) and Gross Margin (2016-2018)
Table Wuhan Institute of Biological Products Recent Development
Table Lanzhou Institute of Biological Products Company Details
Table Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Sales (K doses), Revenue (Million US$), Price (USD/dose) and Gross Margin (2016-2018)
Table Lanzhou Institute of Biological Products Recent Development
Table Hualan Biological Engineering Company Details
Table Hualan Biological Engineering Meningococcal Infections Vaccine Sales (K doses), Revenue (Million US$), Price (USD/dose) and Gross Margin (2016-2018)
Table Hualan Biological Engineering Recent Development
Table Chongqing Zhifei Biological Products Company Details
Table Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Sales (K doses), Revenue (Million US$), Price (USD/dose) and Gross Margin (2016-2018)
Table Chongqing Zhifei Biological Products Recent Development
Table Zhejiang Tianyuan Bio-Pharmaceutical Company Details
Table Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Sales (K doses), Revenue (Million US$), Price (USD/dose) and Gross Margin (2016-2018)
Table Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
Table Walvax Biotechnology Company Details
Table Walvax Biotechnology Meningococcal Infections Vaccine Sales (K doses), Revenue (Million US$), Price (USD/dose) and Gross Margin (2016-2018)
Table Walvax Biotechnology Recent Development
Table Royal(Wuxi) Bio-Pharmaceutical Company Details
Table Royal(Wuxi) Bio-Pharmaceutical Meningococcal Infections Vaccine Sales (K doses), Revenue (Million US$), Price (USD/dose) and Gross Margin (2016-2018)
Table Royal(Wuxi) Bio-Pharmaceutical Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Meningococcal Infections Vaccine Value Chain
Table Typical Suppliers of Key Meningococcal Infections Vaccine Raw Material
Table Meningococcal Infections Vaccine Customers List
Table Meningococcal Infections Vaccine Sales Channels
Table Meningococcal Infections Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type